SUBSCRIBE
SUBSCRIBE
News   Deals

Sanofi-Aventis (France) Reported Weighing Higher Genzyme Corporation Offer

September 29, 2010 | 
1 min read
PARIS/LONDON (Reuters) - Sanofi-Aventis (SASY.PA) is considering whether to raise its $18.5 billion bid for U.S. drugmaker Genzyme (GENZ.O) as soon as next week, Bloomberg said on Wednesday, citing people with knowledge of the matter.
Mergers & acquisitions Europe
Sanofi (France)
MORE ON THIS TOPIC
People balance on tightly stretched ropes. Art collage.
Deals
M&A, IPOs Snarled by Policy Reality in Q1 as Pharmas Opt for Licensing Deals
May 7, 2025
 · 
3 min read
 · 
Annalee Armstrong
Brain shaped maze. Conceptual image of science and medicine. 3D illustration.
ALS
Lilly Deepens ALS Pipeline With $415M Alchemab Licensing Deal
May 6, 2025
 · 
2 min read
 · 
Tristan Manalac
Business and financial crisis vector concept with businessman falling down the hole. Symbol of market crash, recession, risk, bankruptcy and loss. Eps10 illustration.
Mergers & acquisitions
Kronos Accepts $35M Concentra Buyout as Walls Close In
May 2, 2025
 · 
2 min read
 · 
Annalee Armstrong
Creative design. Desperate employee, office worker standing near question mark symbolizing business struggles, options. Choosing strategy for achieving goal. Concept of business, career development
Earnings
Tariffs Keep Biogen Execs Busy in Q1 but Impacts Expected To Be Minimal
May 1, 2025
 · 
3 min read
 · 
Annalee Armstrong